Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

133 Press Releases
DateTitleCompany
18 Jan 13 Forest Laboratories, Inc. Announces Health Canada Approval of BYSTOLIC for the Treatment of Hypertension Forest Laboratories Inc.,
Published by
Business Wire
15 Jan 13 Forest Laboratories, Inc. Reports Fiscal Year 2013 Third Quarter Earnings Forest Laboratories Inc.,
Published by
Business Wire
03 Jan 13 Forest Laboratories, Inc. Announces Additional Settlement Agreement in BYSTOLIC® Patent Litigation Forest Laboratories Inc.,
Published by
Business Wire
03 Jan 13 Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2013 Third Quarter Earnings Forest Laboratories Inc.,
Published by
Business Wire
17 Dec 12 Ironwood and Forest Announce U.S. Availability of LINZESS™ (Linaclotide) Forest Laboratories Inc. & Ironwood Pharmaceuticals Inc.,
Published by
Business Wire
11 Dec 12 Forest Laboratories and Almirall announce commercial availability of Tudorza™ Pressair™ in US pharmacies Forest Laboratories Inc.,
Published by
Business Wire
04 Dec 12 Forest Laboratories, Inc. to Present Cariprazine Results from a Phase 3 Trial and Two Pharmacology Studies at the American College of Neuropsychopharmacology (ACNP) Annual Meeting Forest Laboratories Inc.,
Published by
Business Wire
29 Nov 12 Forest Laboratories, Inc. Announces Additional Settlement Agreements in BYSTOLIC® Patent Litigation Forest Laboratories Inc.,
Published by
Business Wire
28 Nov 12 Forest Laboratories Submits New Drug Application for Cariprazine for the Treatment of Both Schizophrenia and Manic or Mixed Episodes Associated with Bipolar I Disorder Forest Laboratories Inc.,
Published by
Business Wire
14 Nov 12 Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR® and Donepezil for Alzheimer’s Disease Forest Laboratories Inc.,
Published by
Business Wire
26 Oct 12 Forest Laboratories, Inc. Announces Settlement Agreement with Hetero Labs Ltd. in BYSTOLIC® Patent Litigation Forest Laboratories Inc.,
Published by
Business Wire
23 Oct 12 Forest Laboratories and moksha8 Form Broad Strategic Alliance for Latin America Forest Laboratories Inc.,
Published by
Business Wire
16 Oct 12 Forest Laboratories, Inc. Reports Fiscal Year Second Quarter 2013 GAAP Earnings Per Share of $0.08 Forest Laboratories Inc.,
Published by
Business Wire
01 Oct 12 Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2013 Second Quarter Earnings Forest Laboratories Inc.,
Published by
Business Wire
27 Sep 12 Forest Laboratories Submits New Drug Application for Levomilnacipran for the Treatment of Major Depressive Disorder Forest Laboratories Inc.,
Published by
Business Wire
01 Sep 12 ADDING MULTIMEDIA Ironwood and Forest Announce FDA Approval of LINZESSTM (Linaclotide) for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation Forest Laboratories Inc. & Ironwood Pharmaceuticals Inc.,
Published by
Business Wire
31 Aug 12 Ironwood and Forest Announce FDA Approval of LINZESSTM (Linaclotide) for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation Forest Laboratories Inc. & Ironwood Pharmaceuticals Inc.,
Published by
Business Wire
28 Aug 12 Forest Laboratories Adopts Stockholder Rights Plan and Declares Dividend Distribution of Preferred Share Purchase Rights Forest Laboratories Inc.,
Published by
Business Wire
15 Aug 12 Forest Announces Preliminary Results of Annual Meeting of Shareholders Forest Laboratories Inc.,
Published by
Business Wire
13 Aug 12 Forest Laboratories Issues Open Letter to Shareholders Forest Laboratories Inc.,
Published by
Business Wire
11 Aug 12 Forest Laboratories Responds to False and Misleading Statements by Carl Icahn Forest Laboratories Inc.,
Published by
Business Wire
06 Aug 12 Forest Laboratories to File Investor Presentation and White Paper Forest Laboratories Inc.,
Published by
Business Wire
02 Aug 12 Glass Lewis Recommends Forest Shareholders Elect Company’s Entire Slate of Ten Board Nominees Forest Laboratories Inc.,
Published by
Business Wire
02 Aug 12 Forest Laboratories Comments on ISS Report Forest Laboratories Inc.,
Published by
Business Wire
31 Jul 12 Forest Laboratories Responds to Icahn Filing Forest Laboratories Inc.,
Published by
Business Wire
28 Jul 12 Forest Pleased with Delaware Court’s Decision on Icahn Litigation Forest Laboratories Inc.,
Published by
Business Wire
27 Jul 12 Forest Laboratories Filed Investor Presentation Forest Laboratories Inc.,
Published by
Business Wire
24 Jul 12 Forest Laboratories Files Investor Presentation Forest Laboratories Inc.,
Published by
Business Wire
24 Jul 12 Forest Laboratories and Almirall Announce FDA Approval of Tudorza™ Pressair™ for the Long-Term Maintenance Treatment of COPD Forest Laboratories Inc.,
Published by
Business Wire
17 Jul 12 Forest Laboratories, Inc. Reports Fiscal Year First Quarter 2013 Earnings Per Share of $0.21 Forest Laboratories Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.